Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,751 | -11,165 | -4,543 | -21,698 | -16,886 |
| Depreciation Amortization | 274 | 139 | 59 | 115 | 74 |
| Accounts receivable | 2,047 | 2,026 | 2,004 | -972 | -747 |
| Other Working Capital | 3,705 | 2,631 | 1,930 | 3,967 | 1,378 |
| Other Operating Activity | -176 | -625 | -1,135 | 3,992 | 3,062 |
| Operating Cash Flow | $-12,901 | $-6,995 | $-1,685 | $-14,595 | $-13,119 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -568 | -195 | -68 | -1,178 | -671 |
| Investing Cash Flow | $-568 | $-195 | $-68 | $-1,178 | $-671 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,885 | 1,110 | N/A | 15,949 | 15,949 |
| Other Financing Activity | -167 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $11,718 | $1,110 | $N/A | $15,949 | $15,949 |
| Exchange Rate Effect | 16 | 36 | -8 | -4 | 22 |
| Beginning Cash Position | 17,682 | 17,682 | 17,682 | 17,510 | 17,510 |
| End Cash Position | 15,947 | 11,638 | 15,921 | 17,682 | 19,690 |
| Net Cash Flow | $-1,735 | $-6,044 | $-1,761 | $172 | $2,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,901 | -6,995 | -1,685 | -14,595 | -13,119 |
| Capital Expenditure | -568 | -195 | -68 | -1,178 | -671 |
| Free Cash Flow | -13,469 | -7,190 | -1,753 | -15,773 | -13,789 |